EUVIMEDEUVIMED entdecken
Crossref

Gliptin induced acute pancreatitis: a literature review

C Lambrechts, S Chhajlani, O Islam, L Verbruggen, C De Weerdt, L Mariën, M Simoens, M Ulenaers, D Galdermans, W Demey, I Van der Massen, W Lybaert und 1 weitere

Acta Gastro Enterologica Belgica · 2025

DOI: 10.51821/88.1.13722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Gastro Enterologica Belgica, 2025. Verfasst von C Lambrechts und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastro-Enterology, Heilig Hart Ziekenhuis, Mol, Belgium. Hauptthemen laut MEDLINE: Capecitabine, Neuroendocrine Tumors, Temozolomide, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between dipeptidyl peptidase-4 (DPP-4) inhibitors, known as gliptins, and acute pancreatitis raises growing concern. A systematic search of PubMed, Scopus and Web of Science was conducted for studies published between January 2005 and July 2024. Studies focusing on gliptin-induced pancreatitis were selected based on predefined criteria. While gliptins are effective in managing type 2 diabetes mellitus, several case reports and observational studies suggest a potential risk for inducing acute pancreatitis. Proposed mechanisms include increased pancreatic activity and cellular stress. Clinical presentation often includes abdominal pain and elevated pancreatic enzymes, necessitating prompt diagnosis and discontinuation of the offending agent. Early recognition and management, including discontinuation of the drug and supportive care, are crucial. Balancing benefits and risks of gliptin therapy is essential for ensuring patient safety and optimal outcomes. This review underscores the importance of vigilance among healthcare providers and the need for further research to develop safer therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapecitabineNeuroendocrine TumorsTemozolomideAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultBelgiumTreatment Outcome

Stichwörter der Autor:innen

CAPTEMefficacyneuroendocrine tumorssafety

Substanzen

CapecitabineTemozolomide

Autor:innen und Institutionen

  • Department of Gastro-Enterology, Heilig Hart Ziekenhuis, Mol, Belgium.
  • Department of Medical Oncology, Antwerp University Hospital ? NETwerk, Antwerp, Belgium.
  • Integrated Personalized and Precision Oncology Network (IPPON), Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.
  • Center for Medical Genetics (CMG), University of Antwerp, Antwerp, Belgium.
  • Department of Gastro-Enterology, Ziekenhuis Aan Stroom (ZAS) ? NETwerk,Antwerp, Belgium.
  • Department of Gastro-Enterology, AZ Rivierenland - NETwerk, Bornem, Belgium.

Zitieren

APA

Lambrechts, C., Chhajlani, S., Islam, O., Verbruggen, L., De Weerdt, C., Mariën, L., Simoens, M., Ulenaers, M., Galdermans, D., Demey, W., Van der Massen, I., Lybaert, W., & Vandamme, T. (2025). Gliptin induced acute pancreatitis: a literature review. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/88.1.13722

Vancouver

Lambrechts C, Chhajlani S, Islam O, Verbruggen L, De Weerdt C, Mariën L, et al. Gliptin induced acute pancreatitis: a literature review. Acta Gastro Enterologica Belgica. 2025. doi:10.51821/88.1.13722

BibTeX
@article{Lambrechts2025,
  author = {Lambrechts, C and Chhajlani, S and Islam, O and Verbruggen, L and De Weerdt, C and Mariën, L and Simoens, M and Ulenaers, M and Galdermans, D and Demey, W and Van der Massen, I and Lybaert, W and Vandamme, T},
  title = {Gliptin induced acute pancreatitis: a literature review},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2025},
  doi = {10.51821/88.1.13722}
}
Kostenlos starten →